DK0876146T3 - Nucleoside analoger i kombinationsterapi af herpes simplex infektioner - Google Patents

Nucleoside analoger i kombinationsterapi af herpes simplex infektioner

Info

Publication number
DK0876146T3
DK0876146T3 DK97901694T DK97901694T DK0876146T3 DK 0876146 T3 DK0876146 T3 DK 0876146T3 DK 97901694 T DK97901694 T DK 97901694T DK 97901694 T DK97901694 T DK 97901694T DK 0876146 T3 DK0876146 T3 DK 0876146T3
Authority
DK
Denmark
Prior art keywords
combination therapy
herpes simplex
nucleoside analogues
simplex infections
infections
Prior art date
Application number
DK97901694T
Other languages
English (en)
Inventor
Malcolm Richard Smithklin Boyd
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0876146(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Application granted granted Critical
Publication of DK0876146T3 publication Critical patent/DK0876146T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97901694T 1996-01-26 1997-01-24 Nucleoside analoger i kombinationsterapi af herpes simplex infektioner DK0876146T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601544.1A GB9601544D0 (en) 1996-01-26 1996-01-26 Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (en) 1996-01-26 1997-01-24 Nucleoside analogs in combination therapy of herpes simplex infections

Publications (1)

Publication Number Publication Date
DK0876146T3 true DK0876146T3 (da) 2003-08-11

Family

ID=10787583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97901694T DK0876146T3 (da) 1996-01-26 1997-01-24 Nucleoside analoger i kombinationsterapi af herpes simplex infektioner

Country Status (25)

Country Link
US (5) US6514980B1 (da)
EP (1) EP0876146B1 (da)
JP (1) JP2000507211A (da)
KR (1) KR19990081966A (da)
CN (1) CN1133433C (da)
AR (1) AR005551A1 (da)
AT (1) ATE238796T1 (da)
AU (1) AU713202B2 (da)
BR (1) BR9707304A (da)
CY (1) CY2421B1 (da)
CZ (1) CZ297841B6 (da)
DE (1) DE69721484T2 (da)
DK (1) DK0876146T3 (da)
ES (1) ES2199339T3 (da)
GB (1) GB9601544D0 (da)
HU (1) HU226793B1 (da)
IL (1) IL125075A (da)
NO (1) NO316355B1 (da)
NZ (1) NZ326839A (da)
PL (1) PL187076B1 (da)
PT (1) PT876146E (da)
TR (1) TR199801439T2 (da)
TW (1) TW493985B (da)
WO (1) WO1997026882A1 (da)
ZA (1) ZA97608B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7591945B2 (en) * 2003-02-07 2009-09-22 Gambro Lundia Ab Support device for containers in extracorporeal blood treatment machines
CN104997783A (zh) * 2005-03-25 2015-10-28 Alt解决方案公司 端粒酶阳性细胞中端粒长度的调节和癌症治疗
US8609623B2 (en) * 2005-05-18 2013-12-17 Alt Solutions Inc. Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) * 2019-05-23 2019-07-10 Douglas Pharmaceuticals Ltd Treatment of conditions
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) * 1964-09-03 1967-05-30 Merck & Co Inc Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
ES2096215T3 (es) 1992-10-01 1997-03-01 Wellcome Found Tucaresol como agente inmunopotenciador.
GB9426021D0 (en) 1994-12-22 1995-02-22 Smithkline Beecham Plc Pharmaceuticals
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections

Also Published As

Publication number Publication date
JP2000507211A (ja) 2000-06-13
WO1997026882A1 (en) 1997-07-31
ES2199339T3 (es) 2004-02-16
TR199801439T2 (xx) 1998-10-21
PT876146E (pt) 2003-09-30
HK1016475A1 (en) 1999-11-05
GB9601544D0 (en) 1996-03-27
HUP9900945A2 (hu) 1999-07-28
CY2421B1 (en) 2004-11-12
ATE238796T1 (de) 2003-05-15
CZ297841B6 (cs) 2007-04-11
HU226793B1 (en) 2009-10-28
AU1550697A (en) 1997-08-20
HUP9900945A3 (en) 2001-02-28
NZ326839A (en) 2001-02-23
AU713202B2 (en) 1999-11-25
EP0876146A1 (en) 1998-11-11
NO983402L (no) 1998-07-23
US20050222016A1 (en) 2005-10-06
CN1209748A (zh) 1999-03-03
NO983402D0 (no) 1998-07-23
TW493985B (en) 2002-07-11
IL125075A0 (en) 1999-01-26
ZA97608B (en) 1998-07-24
PL327917A1 (en) 1999-01-04
US20080287389A1 (en) 2008-11-20
US20100323952A1 (en) 2010-12-23
IL125075A (en) 2003-02-12
EP0876146B1 (en) 2003-05-02
US6514980B1 (en) 2003-02-04
CN1133433C (zh) 2004-01-07
PL187076B1 (pl) 2004-05-31
NO316355B1 (no) 2004-01-19
DE69721484D1 (de) 2003-06-05
BR9707304A (pt) 1999-07-20
KR19990081966A (ko) 1999-11-15
CZ234098A3 (cs) 1999-02-17
US20040185433A1 (en) 2004-09-23
DE69721484T2 (de) 2004-02-26
AR005551A1 (es) 1999-06-23

Similar Documents

Publication Publication Date Title
CY2006008I2 (el) Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
DK0915880T3 (da) Azolotriaziner og pyrimidiner
DK1498124T3 (da) Anvendelse af inhibitorer i renin-angiotensinsystemet
FI944134L (fi) Virustenvastaisia nukleosidianalogeja
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
FI940167A0 (fi) Puriinijohdannaisia
DK0983271T3 (da) Carbocyklisk nucleosidhemisulfat og anvendelsen deraf i behandlingen af virusinfektioner
NO983402D0 (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
DK1140937T3 (da) Antivirale nucleosid-analoger
BR9509986A (pt) Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes
NO995620D0 (no) Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89
BR9406575A (pt) Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
FI964468A0 (fi) Adenosiinijohdannaisia
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
FI956246L (fi) Hiili-asykliset nukleosidijohdannaiset antiviraalisina ja antineoplastisina aineina
DK0850246T3 (da) Pyrimidinnukleosidderivater
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
DK98093D0 (da) Herpesmiddel
KR970061559U (ko) 프론트 컴비네이션 램프의 측면 결합구조
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes